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Background: Troponin elevation in the setting of acute pulmonary embolism (PE) is of small magnitude and short duration and can go unnoticed 
in pts referred late after symptom onset.
Methods: Prospective, single-center registry of pts ients with confirmed intermediate-risk PE, defined as at least 1 echocardiographic finding of 
right ventricular (RV) dysfunction (RV/left ventricular end-diastolic diameter ratio >=1 in the 4-chamber view, paradoxical septal systolic motion or 
pulmonary hypertension defined as RV/atrial gradient >30mmHg), or positive troponin test. Combined in-hospital endpoint was defined as death, 
non-fatal recurrent PE, or residual pulmonary vascular obstruction (RPVO) >35%.
Results: 282 pts were included, age 66±14 years, 59% women, 174 (62%) referred ≤5 days after symptom onset, 108 (38%) after >5 days. 
Troponin elevation was observed in 126 (72%) treated within ≤5 days, in 60 (56%) treated after >5 days (p=0.004). Prognostic value is shown in 
table. Positive troponin was an independent predictor of adverse outcome (OR=1.43 [1.08-5.56]). ROC curves show that prognostic value of positive 
troponin test was lower in pts referred ≤5 days than in pts referred > 5 days after symptom onset (p=0.01).
Conclusion: There is a significant relation between troponin elevation and symptom onset in patients with intermediate-risk PE. Negative 
predictive value of troponin elevation is adequate in pts treated early (≤5 days) but is suboptimal in pts treated >5 days after symptom onset. 
<=5 days since symptom onset >5 days since symptom onset p
Sensitivity 72% (61.3-82.7) 51% (42.4-59.6) 0.005
Specificity 42% (44.5-49.5) 47% (39.1-54.9) 0.33
PPV 26% (18.4-33.6) 30% (22.2-37.8) 0.81
NPV 85% (78.4-91.6) 70% (63-77) 0.002
